跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Angirel MR - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Angirel MR
Approved
STANDARD
Angirel MR
Unison Laboratories Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c546df1e9df96afe
Company
Unison Laboratories Co., Ltd.
Type
Standard
Approval Details
Approval Id
c546df1e9df96afe
Drug Approval Philippines Name
Angirel MR
Product Name
Angirel MR
Registration Number
DR-XY45017
Brand Name
Angirel MR
Generic Name
Trimetazidine Hydrochloride
Dosage Form
Modified-Release Tablet
Dosage Strength
35 mg
Manufacturer
Unison Laboratories Co., Ltd.
Importer
JustRight Healthcare Inc
Distributor
JustRight Healthcare Inc.
Issuance Date
28 January 2025
Expiry Date
22 February 2026
Pharmacologic Category
Anti-Angina
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c546df1e9df96afe
Type
Standard
Back to Philippines FDA Approvals